Brief: Pharmaxis To Receive 2.9M EUR From Parkinson's Uk For Phase 2 Parkinson's Disease Clinical Trial

Syntara

01/09/2022 02:45

Sept 1 (Reuters) - Pharmaxis  PXS.AX :
    * TO RECEIVE 2.9M EUR FROM PARKINSON'S UK FOR PHASE 2
PARKINSON'S
DISEASE CLINICAL TRIAL

Source text for Eikon:  ID:nASX18dmcX 
Further company coverage:  PXS.AX 

 ((Reuters.Briefs@thomsonreuters.com;))